Demant CEO: It will take a long time to meet pent-up demand

That millions of people have not been able to get their hearing aids adjusted due to the pandemic has caused a huge backlog, and according to Demant CEO Søren Nielsen, this will impact the industry for some time.

Demant CEO Søren Nielsen | Photo: Kenneth Lysbjerg Koustrup/ERH

The global hearing aid market is gearing up again after the corona pandemic, but there are still large regional differences from country to country.

Restrictions are still in place in many regions and have differed widely throughout the pandemic. However, the general business foundation is intact, the large hearing aid manufacturers are concluding.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Lundbeck chairman demands change: "We can't live with this"

Years of work developing new treatments at Lundbeck has so far come to nothing. This has led chairman Lars Rasmusssen to demand visible results, even though CEO Deborah Dunsire has essentially had to restart development work since she joined the firm in 2018.

Eli Lilly upgrades earnings per share guidance

On Tuesday, US-based pharmaceutical firm Eli Lilly has updated elements of its 2021 financial guidance pertaining to earnings per share (non-GAAP), now expecting USD 7.95-8.05 compared to the previous USD 7.8-8.

Further reading

Related articles

Trial banner

Latest news

See all jobs